Potential association of vitamin D receptor polymorphism Taq1 with multiple sclerosis

Multiple Sclerosis Journal

Volumn 18, Issue 1, 2012, Pages 16-22

  Cox, Mathew B ^a   Ban, Maria ^b   Bowden, Nikola A ^a   Baker, Amie ^b   Scott, Rodney J ^a   Lechner Scott, Jeannette ^a,c  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c JOHN HUNTER HOSPITAL   (Australia)

Author keywords

epistasis; genetic; genetics; HLA DRB1, 1501; human; multiple sclerosis; single nucleotide polymorphism; vitamin D receptor

Indexed keywords

HLA DR ANTIGEN; VITAMIN D RECEPTOR;

ALLELE; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; EPISTASIS; EXPANDED DISABILITY STATUS SCALE; FAMILY; GENETIC POLYMORPHISM; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84855930078     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458511415562     Document Type: Article

References (44)

1. Coles A. Multiple sclerosis. Pract Neurol. 2009 ; 9: 118-126
2. Nischwitz S, Müller-Myhsok B, Weber F. Risk conferring genes in multiple sclerosis. FEBS Letters. 2011 ;:
3. Schmidt H, Williamson D, Ashley-Koch A. HLA-DR15 haplotype and multiple sclerosis: A HuGE review. Am J Epidemiol. 2007 ; 165: 1097-1109 (Pubitemid 47233710)
4. De Jager PL, Jia X, Wang J, et al. Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. Nat Genet. 2009 ; 41: 776-782
5. Ascherio A, Munger K. Epstein-Barr virus infection and multiple sclerosis: A review. J Neuroimmune Pharmacol. 2010 ; 5: 271-277
6. Handel AE, Williamson AJ, Disanto G, Dobson R, Giovannoni G, Ramagopalan SV. Smoking and multiple sclerosis: An updated meta-analysis. PLoS one. 2011 ; 6: e16149
7. Simpson S, Blizzard L, Otahal P, Van der Mei I, Taylor B. Latitude is significantly associated with the prevalence of multiple sclerosis: A meta-analysis. J Neurol, Neurosurg Psychiatry. 2011 ;:
8. Alonso A, Hernan MA. Temporal trends in the incidence of multiple sclerosis: A systematic review. Neurology. 2008 ; 71: 129-135
9. McLeod JG. Multiple sclerosis in Australia. J Clin Neurosci. 1997 ; 4: 425-431 (Pubitemid 127674830)
10. Taylor BV, Lucas RM, Dear K, et al. Latitudinal variation in incidence and type of first central nervous system demyelinating events. Mult Scler. 2010 ; 16: 398-405
11. Correale J, Ysrraelit MC, Gaitan MI. Immunomodulatory effects of vitamin D in multiple sclerosis. Brain. 2009 ; 132: 1146-1160
12. Simpson S, Taylor B, Blizzard L, et al. Higher 25-hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis. Ann Neurol. 2010 ; 68: 193-203
13. Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA. 2006 ; 296: 2832-2838 (Pubitemid 44969183)
14. Ramagopalan SV, Maugeri NJ, Handunnetthi L, et al. Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1*1501 is regulated by vitamin D. PLoS Genet. 2009 ; 5: e1000369
15. Fukazawa T, Yabe I, Kikuchi S, et al. Association of vitamin D receptor gene polymorphism with multiple sclerosis in Japanese. J Neurol Sci. 1999 ; 166: 47-52 (Pubitemid 29327245)
16. Niino M, Fukazawa T, Yabe I, Kikuchi S, Sasaki H, Tashiro K. Vitamin D receptor gene polymorphism in multiple sclerosis and the association with HLA class II alleles. J Neurol Sci. 2000 ; 177: 65-71
17. Steckley JL, Dyment DA, Sadovnick AD, Risch N, Hayes C, Ebers GC. Genetic analysis of vitamin D related genes in Canadian multiple sclerosis patients. Canadian Collaborative Study Group. Neurology. 2000 ; 54: 729-732 (Pubitemid 30082946)
18. Partridge JM, Weatherby SJ, Woolmore JA, et al. Susceptibility and outcome in MS: Associations with polymorphisms in pigmentation-related genes. Neurology. 2004 ; 62: 2323-2325 (Pubitemid 38787801)
19. Yeo TW, Maranian M, Singlehurst S, Gray J, Compston A, Sawcer S. Four single nucleotide polymorphisms from the vitamin D receptor gene in UK multiple sclerosis. J Neurol. 2004 ; 251: 753-754 (Pubitemid 38824024)
20. Tajouri L, Ovcaric M, Curtain R, et al. Variation in the vitamin D receptor gene is associated with multiple sclerosis is an Australian population. J Neurogenet. 2005 ; 19: 25-38 (Pubitemid 41656874)
21. Orton SM, Morris AP, Herrera BM, et al. Evidence for genetic regulation of vitamin D status in twins with multiple sclerosis. Am J Clin Nutr. 2008 ; 88: 441-447
22. Dickinson JL, Perera DI, van der Mei AF, et al. Past environmental sun exposure and risk of multiple sclerosis: A role for the Cdx-2 vitamin D receptor variant in this interaction. Mult Scler. 2009 ; 15: 563-570
23. Smolders J, Damoiseaux J, Menheere P, Tervaert JWC, Hupperts R. Fok-I vitamin D receptor gene polymorphism (rs10735810) and vitamin D metabolism in multiple sclerosis. J Neuroimmunol. 2009 ; 207: 117-121
24. Smolders J, Damoiseaux J, Menheere P, Tervaert JWC, Hupperts R. Assoication study on two vitamin D receptor gene polymorphisms and vitamin D metabolites in multiple sclerosis. Contemporary Challenges in Autoimmunity. 2009 ; 1179: 515-520
25. Simon KC, Munger KL, Xing Y, Ascherio A. Polymorphisms in vitamin D metabolism related genes and risk of multiple sclerosis. Mult Scler. 2010 ; 16: 133-138
26. Yeo TW, De Jager PL, Gregory SG, et al. A second major histocompatibility complex susceptibility locus for multiple sclerosis. Ann Neurol. 2007 ; 61: 228-236 (Pubitemid 46557347)
27. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the 'McDonald Criteria'. Ann Neurol. 2005 ; 58: 840-846 (Pubitemid 41746873)
28. GaudermanWMorrisonJ. QUANTO 1.1: A computer program for power and sample size calculations for genetic-epidemiology studies, http://hydra.usc.edu/gxe (2006, accessed XXXXX XXXX).
29. O'Connell JR, Weeks DE. PedCheck: A program for identification of genotype incompatibilities in linkage analysis. Am J Hum Genet. 1998 ; 63: 259-266 (Pubitemid 30428342)
30. Dudbridge F. Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data. Hum Hered. 2008 ; 66: 87-98 (Pubitemid 351482562)
31. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics. 2005 ; 21: 263-265 (Pubitemid 40202029)
32. Goris A, Walton A, Ban M, Dubois B, Compston A, Sawcer S. A Taqman assay for high-throughput genotyping of the multiple sclerosis-associated HLA-DRB1*1501 allele. Tissue Antigens. 2008 ; 72: 401-403
33. Dudbridge F Unphased user guide. Cambridge, UK: MRC Biostatistics Unit ; 2006:
34. Uitterlinden AG, Fang Y, van Meurs JB, van Leeuwen H, Pols HA. Vitamin D receptor gene polymorphisms in relation to vitamin D related disease states. J Steroid Biochem Mol Biol. 2004 ; 89-90: 187-193 (Pubitemid 38844281)
35. Uitterlinden AG, Fang Y, Van Meurs JB, Pols HA, Van Leeuwen JP. Genetics and biology of vitamin D receptor polymorphisms. Gene. 2004 ; 338: 143-156 (Pubitemid 39094759)
36. Jurutka PW, Remus LS, Whitfield GK, et al. The polymorphic N terminus in human vitamin D receptor isoforms influences transcriptional activity by modulating interaction with transcription factor IIB. Mol Endocrinol. 2000 ; 14: 401-420 (Pubitemid 32260532)
37. Ramos-Lopez E, Kurylowicz A, Bednarczuk T, Paunkovic J, Seidl C, Badenhoop K. Vitamin D receptor polymorphisms are associated with Graves' disease in German and Polish but not in Serbian patients. Thyroid. 2005 ; 15: 1125-1130 (Pubitemid 41720718)
38. Raimondi S, Johansson H, Maisonneuve P, Gandini S. Review and meta-analysis on vitamin D receptor polymorphisms and cancer risk. Carcinogenesis. 2009 ; 30: 1170-1180
39. van Etten E, Verlinden L, Giulietti A, et al. The vitamin D receptor gene FokI polymorphism: Functional impact on the immune system. Eur J Immunol. 2007 ; 37: 395-405 (Pubitemid 46915579)
40. Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20. Nat Genet. 2009 ; 41: 824-828
41. Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med. 2007 ; 357: 851-862
42. Baranzini SE, Wang J, Gibson RA, et al. Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. Hum Mol Genet. 2009 ; 18: 767-778
43. Burton PR, Clayton DG, Cardon LR, et al. Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet. 2007 ; 39: 1329-1337 (Pubitemid 350041542)
44. Mamutse G, Woolmore J, Pye F, et al. Vitamin D receptor gene polymorphism is associated with reduced disability in multiple sclerosis. Mult Scler. 2008 ; 14: 1280-1283